183 related articles for article (PubMed ID: 36140839)
1. The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal
van Hooijdonk CFM; Tse DHY; Roosenschoon J; Ceccarini J; Booij J; van Amelsvoort TAMJ; Vingerhoets C
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140839
[TBL] [Abstract][Full Text] [Related]
2. Lower [
van Duin EDA; Ceccarini J; Booij J; Kasanova Z; Vingerhoets C; van Huijstee J; Heinzel A; Mohammadkhani-Shali S; Winz O; Mottaghy F; Myin-Germeys I; van Amelsvoort T
Psychol Med; 2020 Apr; 50(5):799-807. PubMed ID: 30935427
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.
van Duin EDA; Kasanova Z; Hernaus D; Ceccarini J; Heinzel A; Mottaghy F; Mohammadkhani-Shali S; Winz O; Frank M; Beck MCH; Booij J; Myin-Germeys I; van Amelsvoort T
Eur Neuropsychopharmacol; 2018 Jun; 28(6):732-742. PubMed ID: 29703646
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.
Vingerhoets C; Tse DH; van Oudenaren M; Hernaus D; van Duin E; Zinkstok J; Ramaekers JG; Jansen JF; McAlonan G; van Amelsvoort T
J Psychopharmacol; 2020 Aug; 34(8):856-863. PubMed ID: 32448020
[TBL] [Abstract][Full Text] [Related]
5. Riluzole effectively treats psychotic symptoms and improves cognition in 22q11.2 deletion syndrome: A clinical case.
Vingerhoets C; Tse DHY; van Amelsvoort T
Eur J Med Genet; 2019 Aug; 62(8):103705. PubMed ID: 31229682
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
[TBL] [Abstract][Full Text] [Related]
7. The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study.
Rogeau A; Nordio G; Veronese M; Brown K; Nour MM; Osugo M; Jauhar S; Howes OD; McCutcheon RA
Mol Psychiatry; 2022 Aug; 27(8):3493-3500. PubMed ID: 35546633
[TBL] [Abstract][Full Text] [Related]
8. Correlation of striatal dopamine D2/3 receptor availability with GABA level in the anterior cingulate cortex in healthy controls but not in alcohol-dependent subjects and individuals at high risk: A multimodal magnetic resonance spectroscopy and positron emission tomography study.
Spitta G; Gleich T; Rosenthal A; Schubert F; Aydin S; Heinz A; Buchert R; Gallinat J
Addict Biol; 2024 Jun; 29(6):e13424. PubMed ID: 38899357
[TBL] [Abstract][Full Text] [Related]
9. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.
Leurquin-Sterk G; Ceccarini J; Crunelle CL; Weerasekera A; de Laat B; Himmelreich U; Bormans G; Van Laere K
Addict Biol; 2018 May; 23(3):931-944. PubMed ID: 28884874
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
Evers LJ; van Amelsvoort TA; Bakker JA; de Koning M; Drukker M; Curfs LM
Psychopharmacology (Berl); 2015 Sep; 232(18):3319-25. PubMed ID: 26055684
[TBL] [Abstract][Full Text] [Related]
11. Social cognition in 22q11.2 deletion syndrome and idiopathic developmental neuropsychiatric disorders.
Jalal R; Nair A; Lin A; Eckfeld A; Kushan L; Zinberg J; Karlsgodt KH; Cannon TD; Bearden CE
J Neurodev Disord; 2021 Apr; 13(1):15. PubMed ID: 33863277
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in 22q11 deletion syndrome.
da Silva Alves F; Boot E; Schmitz N; Nederveen A; Vorstman J; Lavini C; Pouwels PJ; de Haan L; Linszen D; van Amelsvoort T
PLoS One; 2011; 6(6):e21685. PubMed ID: 21738766
[TBL] [Abstract][Full Text] [Related]
13. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
[TBL] [Abstract][Full Text] [Related]
14. Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls.
Arumuham A; Nour MM; Veronese M; Beck K; Onwordi EC; Lythgoe DJ; Jauhar S; Rabiner EA; Howes OD
Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38373256
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of substance use in people with 22q11.2 deletion syndrome.
Vingerhoets C; van Oudenaren MJF; Bloemen OJN; Boot E; van Duin EDA; Evers LJM; Fiksinski AM; Breetvelt EJ; Palmer LD; Vergaelen E; Vogels A; Meijer C; Booij J; ; de Haan L; Swillen A; Vorstman JAS; Bassett AS; van Amelsvoort TAMJ
Br J Psychiatry; 2019 Nov; 215(5):661-667. PubMed ID: 30604657
[TBL] [Abstract][Full Text] [Related]
17. Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.
Vingerhoets C; Bloemen OJN; Boot E; Bakker G; de Koning MB; da Silva Alves F; Booij J; van Amelsvoort TAMJ
Psychiatry Res Neuroimaging; 2018 Feb; 272():65-70. PubMed ID: 29174435
[TBL] [Abstract][Full Text] [Related]
18. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
Onwordi EC; Whitehurst T; Mansur A; Statton B; Berry A; Quinlan M; O'Regan DP; Rogdaki M; Marques TR; Rabiner EA; Gunn RN; Vernon AC; Natesan S; Howes OD
Transl Psychiatry; 2021 Jul; 11(1):393. PubMed ID: 34282130
[TBL] [Abstract][Full Text] [Related]
19. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
Antshel KM; Fremont W; Ramanathan S; Kates WR
Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
[TBL] [Abstract][Full Text] [Related]
20. Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation.
Lewis CP; Port JD; Blacker CJ; Sonmez AI; Seewoo BJ; Leffler JM; Frye MA; Croarkin PE
Transl Psychiatry; 2020 Apr; 10(1):119. PubMed ID: 32327639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
